Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB (EPOetCEC)

This study has been completed.
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT00273767
First received: January 6, 2006
Last updated: December 4, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)